PROTEOMICS ANALYSIS OF CLEAR CELL RENAL CELL CARCINOMA : IDENTIFICATION OF POTENTIAL TUMOR MARKERS

被引:0
作者
Sun Chuanyang [2 ]
Li Jinmei [1 ]
Sun Wei [2 ]
Hou Chuansheng [2 ]
Zhang Liang [1 ]
机构
[1] Soochow Univ, Coll Med, Sch Pharm, Suzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 2, Dept Urol, Suzhou, Peoples R China
来源
PROGRESS ON POST-GENOME TECHNOLOGIES AND MODERN NATURAL PRODUCTS, 2011 | 2011年
关键词
Renal cell carcinoma; Proteomics analysis; tumor markers; CANCER;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives: Due to the currently inefficient therapies and the low 5-year survival rates of RCC patients, novel diagnostic, prognostic, and therapeutic markers are needed for this disease. Method: The cancer tissues and paracancer normal tissues were preserved in liquid nitrogen. In this report we analyzed the renal cell carcinoma tissues and paracancer normal tissues by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE). The 16 differentially expressed protein spots (p<0.05 by Student t-test) were identified by MALDI-TOF-MS and MS/MS. Results: 6 proteins were downregulated and 10 proteins were upregulated in clear cell RCC. The downregulated proteins were calbindin, ester hydrolase cllorf54, alcohol dehydrogenase, ammecr1-like protein, ADP/ATP translocase 3 and LYR motif-containing protein 5. The upregulated proteins were HIG1 domain family member 1A, Glutathione S-transferase P, Thioredoxin-dependent peroxide reductase, peroxiredoxin-6, CD2-associated protein, Annexin A5, gamma-enolase, retinal dehydrogenase 1, vimentin, and protein-glutamine gamma-glutamyltransferase 2. Conclusion: In brief, our data provide potential tumor markers for diagnosis of RCC.
引用
收藏
页码:202 / 204
页数:3
相关论文
共 8 条
[1]   Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens [J].
Amato, RJ .
ANNALS OF ONCOLOGY, 2005, 16 (01) :7-15
[2]   Key clinical issues in renal cancer: a challenge for proteomics [J].
Banks, Rosamonde E. ;
Craven, Rachel A. ;
Harnden, Patricia ;
Madaan, Sanjeev ;
Joyce, Adrian ;
Selby, Peter J. .
WORLD JOURNAL OF UROLOGY, 2007, 25 (06) :537-556
[3]   Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer [J].
Chang, Xin-Zhong ;
Li, Da-Qiang ;
Hou, Yi-Feng ;
Wu, Jiong ;
Lu, Jin-Song ;
Di, Gen-Hong ;
Jin, Wei ;
Ou, Zhou-Luo ;
Shen, Zhen-Zhou ;
Shao, Zhi-Ming .
BREAST CANCER RESEARCH, 2007, 9 (06)
[4]  
Denko N, 2000, CLIN CANCER RES, V6, P480
[5]   Proteomic analysis of the transition from quiescent to proliferating stages in rat liver hepatectomy model [J].
Guo, Fuzheng ;
Nian, Hui ;
Zhang, Hao ;
Huang, Lingyun ;
Tang, Ying ;
Xiao, Xueyuan ;
He, Dacheng .
PROTEOMICS, 2006, 6 (10) :3075-3086
[6]   Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma [J].
Landriscina, Matteo ;
Altamura, Settimia Anna ;
Roca, Leonarda ;
Gigante, Margherita ;
Piscazzi, Annamaria ;
Cavalcanti, Elisabetta ;
Costantino, Eleonora ;
Barone, Carlo ;
Cignarelli, Mauro ;
Gesualdo, Loreto ;
Ranieri, Elena .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (12) :2842-2850
[7]   Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma [J].
Pasello, Michela ;
Michelacci, Francesca ;
Scionti, Isabella ;
Hattinger, Claudia Maria ;
Zuntini, Monia ;
Caccuri, Anna Maria ;
Scotiandi, Katia ;
Picci, Piero ;
Serra, Massimo .
CANCER RESEARCH, 2008, 68 (16) :6661-6668
[8]   Study of PTPC composition during apoptosis for, identification of viral protein target [J].
Verrier, F ;
Mignotte, B ;
Jan, GN ;
Brenner, C .
APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS, 2003, 1010 :126-142